Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Tivozanib Improves PFS Versus Bevacizumab in NRP-1 Low mCRC

March 10th 2015

Low serum neuropilin-1 may indicate longer progression-free survival with tivozanib compared with bevacizumab as a first-line treatment for patients with metastatic colorectal cancer.

Dr. Cremolini on Identifying Molecular Markers in mCRC

February 25th 2015

Chiara Cremolini, MD, a medical oncologist at the Tuscan Tumor Institute in Pisa, Italy, discusses the necessary steps researchers must take to identify molecular markers in metastatic colorectal cancer (mCRC).

FDA Accepts NDA for TAS-102 in mCRC

February 24th 2015

The FDA has accepted an NDA for the oral nucleoside TAS-102 as a treatment for patients with refractory metastatic colorectal cancer.

Analysis Confirms Safety of Regorafenib in mCRC Among Best Responders

February 14th 2015

Adverse events among patients with metastatic colorectal cancer who responded best to regorafenib in the phase III CORRECT trial were "broadly similar" to the overall study population.

Final Thoughts on Improving Outcomes in CRC

January 30th 2015

Impact of Vitamin D on Colorectal Cancer Outcomes

January 30th 2015

Molecular Profiling in Colorectal Cancer

January 30th 2015

Measuring Therapeutic Response in Colon Cancer

January 30th 2015

Third-Line Regorafenib and TAS-102 in mCRC

January 30th 2015

Second-Line Therapy for Metastatic CRC

January 30th 2015

Postoperative Therapy for Metastatic CRC

January 30th 2015

Treatment Selection in RAS Wild-Type mCRC

January 30th 2015

Communication Strategies for Newly Diagnosed mCRC

January 30th 2015

Expanded RAS Testing Required in CRC

January 30th 2015

Exercise and Lifestyle Factors in Patients with mCRC

January 30th 2015

Adjuvant Therapy in Stage II Colon Cancer

January 30th 2015

Molecular Testing in Colorectal Cancer

January 30th 2015

Colorectal Cancer Screening and Prevention

January 30th 2015

Emerging Therapies for Pancreatic Cancer

January 30th 2015

First- and Second-Line Treatments for Advanced Pancreatic Cancer

January 30th 2015